What problems do CBD, CBG and CBN solve?


Currently there is one CBD-based Federal Drug Administration (FDA) approved treatment drug for epilepsy – Epilodex.


A large amount research is still ongoing there are literally millions of persons reporting relief from pain.

While some of these claims have not been fully vetted yet, the mere fact that these testimonials number in the millions proves that its far more than a mere placebo effect at work here and that CBD assists in these areas.

  • Controls certain cancer
  • Eases pain
  • Stimulates bone growth
  • Stops growth of bacteria
  • Suppresses muscle spasms & convulsions
  • Slows inflammation
  • Reduces blood sugar levels
  • Helps control epileptic seizures
  • Decreased pressure in blood vessel walls
  • Reduces risk of nerve damage
  • Decreased Social Isolated caused by THC
  • Eases nausea
  • Acts as a sleep aid
  • Fights free radicals in blood stream
  • Controls pain
  • Suppresses muscle spasm & convulsions
  • Slows inflammation
  • Stops growth of bacteria
  • Stimulates bone growth
  • Encourages cell growth
  • Eases pain
  • Stops growth of fungi
  • Slows inflammation
  • Encourages cell growth
  • Stops growth of bacteria

In addition, there are several studies that suggest CBD may be an effective treatment for several cognitive decline and brain-related conditions such as: Huntington’s Disease, Alzheimer’s Disease, Post-traumatic stress disorder (PTSD), bipolar disorders, Parkinson’s Disease, & Lou Gehrig’s disease. While more research is needed, results thus far are very promising.

Countless lotions, creams, and salves infused with CBD have reached the retail market in the last 18 months as CBD infused products became a bona fide skin-care trend.  There are data suggesting that CBD infused creams are effective as topical pain relievers. Furthermore, several studies show that such creams decrease oil production and act as an emollient agent smoothing rough cells on the skin’s surface and offering moisturizing benefits.

A 2019 review of clinical studies found that “animal and human studies suggest that [CBD has] the potential to diminish craving and relapse in abstinent substance users and tobacco smokers, by weakening reconsolidation of drug-reward recollection, salience of drug reminders, and inhibiting the reward-facilitating effect of drugs,” and a 2018 double-blind, placebo-controlled study of a mega-dose of CBD (800 mg) for tobacco cessation found that it helped quitters pay less attention to tobacco around them.

Disclosure -- This website contains general information about diet, health and nutrition. The information is not advice and is not a substitute for advice from a healthcare professional.
Food & Drug Administration (FDA) Disclosure -- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
leaf-bulb (002).jpg
Pet & Animal Treatments

CBD products are also being used to treat dogs & cats for certain ailments & while there are no completed formal studies on how CBD affects pets, scientists do know that CBD interacts with the endocannabinoid receptors located in the central & peripheral nervous systems in a similar way as it does in humans, thereby helping to maintain balance in the pet’s body & keep it in a normal healthy state.

There’s a large body of anecdotal evidence from pet owners suggesting CBD can treat pain (especially neuropathic pain), seizures, nausea, stimulation of appetites, anxiety, and possibly cancer prevention (although there’s little conclusive data on its use as a cancer prevention agent)

Potential Customers of CBD, CBG, CBN, CBC based products:
  • 59.4 million people in the US have anxiety (18 percent of US Population on January 1, 2020 - 330,222,422).


  • 16.2 million adults in the United States, or 6.7 percent of American adults, have at least one major depressive episode a year.

  • Nearly everyone experiences bouts of pain - about 3 million persons in the US who experience chronic pain.


  • 3.4 million people in the US have active epilepsy


  • Revenue in US skin care segment - projected to be 18.5 billion in 2019 - growth projections at 3.5 annually.


  • 67 percent of US households own a pet, which equates to 84.9 million homes.

Nekoma, North Dakota  58355
  • Facebook
  • LinkedIn
  • Twitter